Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$45.44 - $74.26 $21.9 Million - $35.7 Million
-481,067 Reduced 38.28%
775,520 $51 Million
Q4 2022

Feb 13, 2023

BUY
$41.39 - $81.0 $15.2 Million - $29.8 Million
367,855 Added 41.39%
1,256,587 $56.5 Million
Q3 2022

Nov 14, 2022

BUY
$72.36 - $113.1 $7.23 Million - $11.3 Million
99,977 Added 12.68%
888,732 $64.3 Million
Q2 2022

Aug 12, 2022

BUY
$87.2 - $114.05 $7.14 Million - $9.33 Million
81,848 Added 11.58%
788,755 $84.6 Million
Q1 2022

May 16, 2022

BUY
$94.19 - $124.49 $11.1 Million - $14.7 Million
118,088 Added 20.06%
706,907 $78.4 Million
Q4 2021

Feb 10, 2022

SELL
$119.57 - $139.07 $711,202 - $827,188
-5,948 Reduced 1.0%
588,819 $75.4 Million
Q3 2021

Nov 12, 2021

SELL
$109.17 - $142.35 $20.3 Million - $26.4 Million
-185,720 Reduced 23.8%
594,767 $79.1 Million
Q2 2021

Aug 10, 2021

BUY
$100.34 - $115.69 $13.5 Million - $15.6 Million
134,612 Added 20.84%
780,487 $84.4 Million
Q1 2021

May 14, 2021

BUY
$101.51 - $125.27 $5.23 Million - $6.46 Million
51,561 Added 8.68%
645,875 $68 Million
Q4 2020

Feb 12, 2021

BUY
$85.88 - $105.36 $5.06 Million - $6.21 Million
58,938 Added 11.01%
594,314 $61.9 Million
Q3 2020

Nov 13, 2020

SELL
$72.74 - $92.5 $37.1 Million - $47.2 Million
-510,185 Reduced 48.8%
535,376 $45.9 Million
Q2 2020

Aug 13, 2020

SELL
$48.02 - $79.04 $6.04 Million - $9.94 Million
-125,752 Reduced 10.74%
1,045,561 $76.6 Million
Q1 2020

May 14, 2020

BUY
$36.95 - $62.95 $4.91 Million - $8.36 Million
132,792 Added 12.79%
1,171,313 $60.9 Million
Q4 2019

Feb 13, 2020

BUY
$47.06 - $56.64 $25.9 Million - $31.1 Million
549,881 Added 112.53%
1,038,521 $58.5 Million
Q3 2019

Nov 08, 2019

BUY
$47.45 - $58.05 $2.73 Million - $3.34 Million
57,580 Added 13.36%
488,640 $23.3 Million
Q2 2019

Aug 13, 2019

SELL
$39.26 - $54.21 $702,204 - $969,600
-17,886 Reduced 3.98%
431,060 $23.4 Million
Q1 2019

May 14, 2019

BUY
$29.84 - $43.92 $3.03 Million - $4.46 Million
101,645 Added 29.27%
448,946 $18.2 Million
Q4 2018

Feb 08, 2019

SELL
$29.95 - $46.34 $17.1 Million - $26.4 Million
-570,715 Reduced 62.17%
347,301 $10.8 Million
Q3 2018

Nov 14, 2018

SELL
$40.12 - $45.55 $3.97 Million - $4.5 Million
-98,898 Reduced 9.73%
918,016 $41.8 Million
Q2 2018

Aug 13, 2018

BUY
$38.72 - $42.52 $39.4 Million - $43.2 Million
1,016,914 New
1,016,914 $42.6 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Westfield Capital Management CO LP Portfolio

Follow Westfield Capital Management CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Westfield Capital Management CO LP with notifications on news.